| 0 (0%) | 12-26 20:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.84  |
1-year : | 6.46 |
| Resists | First : | 5 |
Second : | 5.53 |
| Pivot price | 4.67 |
|||
| Supports | First : | 4.15 |
Second : | 3.45 |
| MAs | MA(5) : | 4.33 |
MA(20) : | 4.77 |
| MA(100) : | 5.39 |
MA(250) : | 0 | |
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 11.2 |
D(3) : | 9.7 |
| RSI | RSI(14): 30.9 |
|||
| 52-week | High : | 8.81 | Low : | 4.01 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ DTIL ] has closed above bottom band by 9.3%. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.41 - 4.45 | 4.45 - 4.48 |
| Low: | 4.06 - 4.12 | 4.12 - 4.15 |
| Close: | 4.17 - 4.26 | 4.26 - 4.31 |
Thu, 25 Dec 2025
Industries Limited (DTIL) - Price Action Trading & Low Entry Cost Investment - bollywoodhelpline.com
Tue, 23 Dec 2025
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent
Tue, 23 Dec 2025
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Wed, 17 Dec 2025
Insider Purchase: Director at $DTIL Buys 3,000 Shares - Quiver Quantitative
Wed, 17 Dec 2025
Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat
Thu, 04 Dec 2025
Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 1.257e+007 (%) |
| Held by Institutions | 5.8 (%) |
| Shares Short | 486 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.792e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -158 % |
| Return on Assets (ttm) | 976.9 % |
| Return on Equity (ttm) | -45.4 % |
| Qtrly Rev. Growth | 698000 % |
| Gross Profit (p.s.) | -88.02 |
| Sales Per Share | -184.83 |
| EBITDA (p.s.) | 628829 |
| Qtrly Earnings Growth | -9 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -73 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 3.4 |
| Dividend | 0 |
| Forward Dividend | 636650 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|